ATEZOLIZUMAB
UNII 52CMI0WC3Y

Substance Identification & Data

This profile provides standardized clinical and technical data for Atezolizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 52CMI0WC3Y.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1380723-44-3 and the RxNorm Concept ID (RxCUI) 1792776. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

52CMI0WC3Y

CAS Registry Number

1380723-44-3

RxNorm Concept ID

1792776

Detailed Substance Profile

Preferred Name

ATEZOLIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

52CMI0WC3Y

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C106250

National Cancer Institute reference terminology for clinical and research data.

INN ID

9814

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

CD-146

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Atezolizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ATEZOLIZUMAB

ATEZOLIZUMAB-TQJC

Common Names & Synonyms

0INE2SFD9E

AN ANTIBODY TO PROGRAMMED DEATH LIGAND 1 FOR CANCER THERAPY

ATEZOLIZUMAB [INN]

ATEZOLIZUMAB [JAN]

ATEZOLIZUMAB [MI]

ATEZOLIZUMAB [PURPLE BOOK CDER]

ATEZOLIZUMAB [USAN]

ATEZOLIZUMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD274) (HUMAN MONOCLONAL MPDL3280A HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MPDL3280A .KAPPA.-CHAIN, DIMER

TECENTRIQ